Molecular and Functional Differences Induced in Thrombospondin-1 by the Single Nucleotide Polymorphism Associated with the Risk of Premature, Familial Myocardial Infarction
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
A serine (Ser-700) amino acid rather than an asparagine (Asn-700) at residue 700 of thrombospondin-1 has been linked to an increased risk for development of premature, familial heart attacks. We now have identified both functional and structural differences between the Ser-700 and Asn-700 thrombospondin-1 variants. The Ser-700 variant increased the rate and extent of platelet aggregation and showed increased surface expression on platelets compared with the Asn-700 variant. These differences could be ascribed to an enhanced interaction of the Ser-700 variant with fibrinogen on the platelet surface and are consistent with a prothrombotic phenotype in Ser-700 individuals. The Ser-700 variant thrombospondin-1 was conformationally more labile than the Asn-700 variant as demonstrated by increased susceptibility to proteolytic digestion and enhanced susceptibility to unfolding by denaturants. These data suggest a potential molecular and cellular basis for a genetic risk factor associated with early onset myocardial infarction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Substitution of serine lowers calcium binding capacity decreasing TSP1 conformational stability but enhancing platelet aggregation [15, 48, 49].”
From Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients (2024) · cites this paper as [49]
In the citing paper
“In SNP rs2228262, changing A to G results in an amino acid change (asparagine to serine) in the calcium binding domain significantly impacts TSP1 structure and function.”
From Thrombospondin-1, BIM and CFH polymorphisms and response to anti-VEGF treatment in neovascular age- related macular degeneration patients (2024) · cites this paper as [49]
Citations
Cites
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness
Van Eerdewegh, P., Little, R. D., Dupuis, J., Del Mastro, R. G., Falls, K., Simon, J., Torrey, D., Pandit, S., McKenny, J., Braunschweiger, K., et al. (2002) · Nature · doi:10.1038/nature00878 · Cited by 1,099
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E
Huo, Y., Schober, A., Forlow, S. B., Smith, D. F., Hyman, M. C., Jung, S., Littman, D. R., Weber, C., & Ley, K. (2003) · Nature Medicine · doi:10.1038/nm810 · Cited by 1,005
A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion Formation
Massberg, S., Brand, K., Grüner, S., Page, S., Müller, E., Müller, I., Bergmeier, W., Richter, T., Lorenz, M., Konrad, I., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012044 · Cited by 879
Stenberg, P. E., McEver, R. P., Shuman, M. A., Jacques, Y. V., & Bainton, D. F. (1985) · The Journal of cell biology · doi:10.1083/jcb.101.3.880 · Cited by 871
Human platelets possess an inducible and saturable receptor specific for fibrinogen.
Marguerie, G. A., Plow, E. F., & Edgington, T. S. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50603-7 · Cited by 706
Self-citationStryer, L. (1968) · Science · doi:10.1126/science.162.3853.526 · Cited by 705
Weiss, E. J., Bray, P. F., Tayback, M., Schulman, S. P., Kickler, T. S., Becker, L. C., Weiss, J. L., Gerstenblith, G., & Goldschmidt-Clermont, P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604253341703 · Cited by 689
Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes
Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M., & Yokota, M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021445 · Cited by 640
[27] Circular dichroism and optical rotatory dispersion of proteins and polypeptides
Adler, A. J., Greenfield, N. J., & Fasman, G. D. (1973) · Methods in Enzymology · doi:10.1016/s0076-6879(73)27030-1 · Cited by 553
Braun, A., Trigatti, B. L., Post, M. J., Sato, K., Simons, M., Edelberg, J. M., Rosenberg, R. D., Schrenzel, M., & Krieger, M. (2002) · Circulation Research · doi:10.1161/hh0302.104462 · Cited by 492
Ligands “activate” integrin αIIbβ3 (platelet GPIIb-IIIa)
Du, X., Plow, E. F., Frelinger, A. L., O'Toole, T. E., Loftus, J. C., & Ginsberg, M. H. (1991) · Cell · doi:10.1016/0092-8674(91)90458-b · Cited by 486
Self-citationThrombospondins as matricellular modulators of cell function
Bornstein, P. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12749 · Cited by 470
Schultz-Cherry, S. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.122.4.923 · Cited by 468
Lawler, J., Sunday, M., Thibert, V, Duquette, M., George, E. L., Rayburn, H., & Hynes, R. O. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1684 · Cited by 457
The functions of thrombospondin-1 and-2
Lawler, J. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00143-5 · Cited by 440
Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.
Lawler, J. W., Slayter, H. S., & Coligan, J. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34336-3 · Cited by 433
Scientific and therapeutic advances in antiplatelet therapy
Bhatt, D. L., & Topol, E. J. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd985 · Cited by 407
Self-citationThrombospondins: Multifunctional Regulators of Cell Interactions
Adams, J. C. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.25 · Cited by 406
The cell biology of thrombospondin-1
Chen, H., Herndon, M. E., & Lawler, J. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00107-4 · Cited by 393
Marguerie, G. A., Edgington, T. S., & Plow, E. F. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86278-6 · Cited by 363
Self-citationTopol, E. J., McCarthy, J., Gabriel, S., Moliterno, D. J., Rogers, W. J., Newby, L. K., Freedman, M., Metivier, J., Cannata, R., O’Donnell, C. J., et al. (2001) · Circulation · doi:10.1161/hc4701.100910 · Cited by 285
Self-citationC-Mannosylation and O-Fucosylation of the Thrombospondin Type 1 Module
Hofsteenge, J., Huwiler, K. G., Macek, B., Hess, D., Lawler, J., Mosher, D. F., & Peter-Katalinic, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008073200 · Cited by 260
The type 1 repeats of thrombospondin 1 activate latent transforming growth factor-beta.
Schultz-Cherry, S., Lawler, J., & Murphy-Ullrich, J. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47087-1 · Cited by 248
The structure of human platelet thrombospondin.
Lawler, J., Derick, L. H., Connolly, J. E., Chen, J. H., & Chao, F. C. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83689-x · Cited by 220
Mosher, D. F. (1990) · Annual Review of Medicine · doi:10.1146/annurev.me.41.020190.000505 · Cited by 188
Calara, F., Silvestre, M., Casanada, F., Yuan, N., Napoli, C., & Palinski, W. (2001) · The Journal of Pathology · doi:10.1002/path.915 · Cited by 167
A monoclonal antibody against human thrombospondin inhibits platelet aggregation.
Dixit, V. M., Haverstick, D. M., O'Rourke, K. M., Hennessy, S. W., Grant, G. A., Santoro, S. A., & Frazier, W. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.10.3472 · Cited by 143
Adams, J. C. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00171-9 · Cited by 135
Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding
Lahav, J., Lawler, J., & Gimbrone, M. A. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08534.x · Cited by 124
C-Mannosylation and O-Fucosylation of Thrombospondin Type 1 Repeats
Gonzalez de Peredo, A., Klein, D., Macek, B., Hess, D., Peter-Katalinic, J., & Hofsteenge, J. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m100011-mcp200 · Cited by 116
Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries
Rießen, R., Kearney, M., Lawler, J., & Isner, J. M. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70105-x · Cited by 101
Bonnefoy, A., Hantgan, R. R., Legrand, C., & Frojmovic, M. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010091200 · Cited by 74
Plow, E., & Marguerie, G. A. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.12.3711 · Cited by 72
Self-citationInteraction of thrombospondin with resting and stimulated human platelets.
Wolff, R. K., Plow, E. F., & Ginsberg, M. H. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62692-x · Cited by 69
Self-citationCHEN, H., SOTTILE, J., STRICKLAND, D. K., & MOSHER, D. F. (1996) · Biochemical Journal · doi:10.1042/bj3180959 · Cited by 68
Thrombospondin-2 Polymorphism Is Associated With a Reduced Risk of Premature Myocardial Infarction
Boekholdt, S. M., Trip, M. D., Peters, R. J. G., Engelen, M., Boer, J. M. A., Feskens, E. J. M., Zwinderman, A. H., Kastelein, J. J. P., & Reitsma, P. H. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000046235.22451.66 · Cited by 67
Legrand, C., Thibert, V., Dubernard, V., Bégault, B., & Lawler, J. (1992) · Blood · doi:10.1182/blood.v79.8.1995.1995 · Cited by 54
Effects of thrombin on washed, human platelets: Chnages in the subcellular fractions
Hagen, I. (1975) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(75)90006-9 · Cited by 47
Aiken, M., Ginsberg, M. H., & Plow, E. (1987) · Blood · doi:10.1182/blood.v69.1.58.58 · Cited by 36
Self-citationLegrand, C., Morandi, V., Mendelovitz, S., Shaked, H. M., Hartman, J. R., & Panet, A. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1784 · Cited by 32
Hannah, B.-L. A., Misenheimer, T. M., Annis, D. S., & Mosher, D. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211185200 · Cited by 28
Takeoka, S., Unoki, M., Onouchi, Y., Doi, S., Fujiwara, H., Miyatake, A., Fujita, K., Inoue, I., Nakamura, Y., & Tamari, M. (2001) · Journal of Human Genetics · doi:10.1007/s100380170109 · Cited by 27
Observation of a High Molecular Weight Platelet Protein Released by Thrombin
Lawler, J., Chao, F. C., & Fang, P.-H. (1977) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649238 · Cited by 25
Mechanisms for Expression of Thrombospondin on the Platelet Cell Surface
Aiken, M. L., Ginsberg, M. H., & Plow, E. F. (1987) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-2007-1003506 · Cited by 23
Self-citationTAP1 gene AccI polymorphism is associated with atopic bronchial asthma
Hang, L., Hsia, T., Chen, W., Chen, H., & Tsai, F. (2003) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.10068 · Cited by 10
Castellino, F. J., Davidson, D. J., Rosen, E. D., & McLinden, J. H. (1993) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(93)23044-n · Cited by 8
Research works printed but not linked: 1
- Peyvandi, 2003, Blood, 102, 11
Cited by
Adams, J. C., & Lawler, J. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009712 · Cited by 457
“Nevertheless, biochemical and cellular analyses of the N700S and A387P SNPs of TSP-1 and TSP-4, respectively, have identified effects on calcium binding, protein conformation, and interactions with cells and ECM components of the vessel wall and platelet clot (Stenina et al. 2003, 2005; Narizhneva et al. 2004; Carlson…”
BackgroundMatricellular Proteins in Cardiac Adaptation and Disease
Frangogiannis, N. G. (2012) · Physiological Reviews · doi:10.1152/physrev.00008.2011 · Cited by 445
“A recent investigation demonstrated that the Ser-700 TSP-1 variant increased the rate and extent of platelet aggregation and showed increased surface expression on platelets compared with the Asn-700 variant (319).”
BackgroundInflammation and metabolic dysfunction: links to cardiovascular diseases
Taube, A., Schlich, R., Sell, H., Eckardt, K., & Eckel, J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00907.2011 · Cited by 238
“Experimental data have shown that TSP-1 stimulates the aggregation and stability of platelet aggregates (188), induces the expression of cell adhesion molecules (189) in endothelial cells, and stimulates chemotaxis in vascular SMCs (147, 191).”
BackgroundThrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses
ISENBERG, J., WINK, D., & ROBERTS, D. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.05.024 · Cited by 132
“Furthermore, a structural polymorphism in TSP1 increases the risk of premature, familial myocardial infarction [49], but the activity of this TSP1 variant to inhibit NO signaling remains to be determined.”
BackgroundPathogenesis of glaucoma: Extracellular matrix dysfunction in the trabecular meshwork‐A review
Keller, K. E., & Peters, D. M. (2022) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.14027 · Cited by 137
Metadata
- Authors
- Narizhneva, N. V., Byers-Ward, V. J., Quinn, M. J., Zidar, F. J., Plow, E. F., Topol, E. J., & Byzova, T. V.
- Affiliations
- Cleveland Clinic (US)
- Corresponding author
- Topol, Eric J.
- Byzova, Tatiana V.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-05
- Volume
- 279
- Issue
- 20
- Pages
- 21651-21657
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC1459418
- OpenAlex
- W1993880593
- Cited by
- 47
- References
- 48
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1 · 2020: 1 · 2018: 1 · 2017: 1 · 2014: 4 · 2013: 1 · 2012: 3
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5988 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL071625., R01HL071625)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Hematology › Blood properties and coagulation
- Keywords
- thrombospondin-1, platelet aggregation, fibrinogen binding, prothrombotic phenotype, protein conformational stability, proteolytic susceptibility, genetic risk factors, platelet surface expression
- MeSH terms
- Asparagine, Circular Dichroism, Humans, Myocardial Infarction, Platelet Aggregation, Risk Factors, Serine, Genetic Variation, Thrombospondin 1, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.